qrh-882260
Peptideexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2015 (NCT02574858)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
EGFR inhibitor
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4594489 ↗
Also known as
- qrh-882260
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03438435 | Phase 1 | Oct 20, 2018 | University of Washington |
| NCT03148119 | Phase 1 | Mar 31, 2017 | University of Michigan |
| NCT02574858 | Phase 1 | Nov 1, 2015 | University of Michigan |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Michigan | Academic/Hospital | 2 | 2 | 1 | 2015 |
| University of Washington | Academic/Hospital | 1 | 1 | 1 | 2018 |
2 organizations
Page 1 / 1